Related Experiment Video
Updated: Mar 20, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
TMEM5-associated dystroglycanopathy presenting with CMD and mild limb-girdle muscle involvement
Guja Astrea1, Ilaria Pezzini1, Ester Picillo2
1IRCCS Stella Maris, Pisa, Italy.
Abstract:
The dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative disorders characterized by variable brain and skeletal muscle involvement. Recently, mutations in TMEM5 have been described in severe dystroglycanopathies. We present the clinical, molecular and neuroimaging features of an Italian boy who had delayed developmental milestones with mild limb-girdle muscle involvement, bilateral frontotemporal polymicrogyria, moderate intellectual disability, and no cerebellar involvement. He also presented a cochlear dysplasia and harbored a reported mutation (p.A47Rfs*42) in TMEM5, detected using targeted next-generation sequencing. The relatively milder muscular phenotype and associated structural brain abnormalities distinguish this case from previously reported patients with severe dystroglycanopathies and expand the spectrum of TMEM5-associated disorders.
Insights
Mutations in TMEM5 gene are linked to dystroglycanopathies. This study details a case with milder muscular and distinct brain abnormalities, expanding the known spectrum of TMEM5-associated disorders.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Dystroglycanopathies are neurodegenerative disorders resulting from impaired alpha-dystroglycan glycosylation.
- Mutations in the TMEM5 gene have recently been associated with severe forms of these conditions.
Observation:
- A case study of an Italian boy with delayed development, mild muscle weakness, and specific brain malformations (polymicrogyria) was analyzed.
- The patient presented with moderate intellectual disability, cochlear dysplasia, and a known TMEM5 mutation (p.A47Rfs*42).
Findings:
- Targeted next-generation sequencing confirmed the TMEM5 mutation.
- The patient exhibited a milder muscular phenotype and unique structural brain abnormalities compared to previously reported severe cases.
Implications:
- This case expands the clinical and genetic spectrum of TMEM5-associated disorders.
- Understanding these variations is crucial for accurate diagnosis and potential therapeutic strategies in dystroglycanopathies.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

